NEW YORK (GenomeWeb) – BioMérieux subsidiary BioFire Defense has received Emergency Use Assessment and Listing (EUAL) from the World Health Organization for its FilmArray BioThreat-E test for the Ebola virus, the company announced today.

With EUAL, the assay is now eligible for WHO procurement.

"This authorization fits our mission to help improve public health through a facilitated access to quality diagnostics," Kirk Ririe, CEO of BioFire Defense, said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.

Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.

La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.